THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Initiating Substance Use Disorder Treatment for Hospitalized Alcohol Use Disorder Patients

Not Applicable

Withdrawn

Conditions: Alcohol Use Disorder

Interventions: Behavioral: In-Hospital Recovery Coach Intervention

First Posted Date: 2020-01-10

Last Posted Date: 2020-07-14

Lead Sponsor: Brigham and Women's Hospital

Registration Number: NCT04223011

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Replication of the EMPAREG Diabetes Trial in Healthcare Claims

Completed

Conditions: Diabetes

Interventions: Drug: DPP-4 inhibitor
Drug: Empagliflozin

First Posted Date: 2020-01-02

Last Posted Date: 2023-07-27

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 103752

Registration Number: NCT04215536

Locations: 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States

Replication of the DECLARE Diabetes Trial in Healthcare Claims

Completed

Conditions: Diabetes

Interventions: Drug: DPP-4 inhibitor
Drug: Dapagliflozin

First Posted Date: 2020-01-02

Last Posted Date: 2023-07-27

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 49790

Registration Number: NCT04215523

Locations: 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States

Return of Genomic Results and Aggregate Penetrance in Population-Based Cohorts

Not Applicable

Conditions: Seemingly Healthy
Genetic Predisposition to Disease

Interventions: Genetic: Genomic Sequencing

First Posted Date: 2019-12-12

Last Posted Date: 2024-04-02

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 110

Registration Number: NCT04196374

Locations: 🇺🇸
Jackson Heart Study, Jackson, Mississippi, United States
🇺🇸
Framingham Heart Study, Framingham, Massachusetts, United States

Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine

Phase 2

Completed

Conditions: Opioid-use Disorder

Interventions: Drug: Cannabidiol 600mg

First Posted Date: 2019-12-10

Last Posted Date: 2023-05-18

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 8

Registration Number: NCT04192370

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Cell-based Therapy for the Treatment of Kidney Disease

Early Phase 1

Not yet recruiting

Conditions: Kidney Diseases

Interventions: Biological: endothelial progenitor cell

First Posted Date: 2019-12-05

Last Posted Date: 2022-07-26

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 10

Registration Number: NCT04187625

Calcium Channel Blockade in Primary Aldosteronism

Phase 2

Completed

Conditions: Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Primary Aldosteronism

Interventions: Drug: Amlodipine

First Posted Date: 2019-11-26

Last Posted Date: 2025-04-15

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 15

Registration Number: NCT04179019

Locations: 🇺🇸
Anand Vaidya, Boston, Massachusetts, United States

Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia

Phase 4

Withdrawn

Conditions: Maternal; Malnutrition, Affecting Fetus
Sexually Transmitted Diseases
Low Birthweight
Urinary Tract Infections
Pregnancy and Infectious Disease
Preterm Birth

Interventions: Drug: Placebo oral tablet 500 mg
Other: Enhanced Infection Management Package (EIMP)
Dietary Supplement: Multiple Micronutrient or Fortified Balanced Energy Protein Supplement
Drug: Azithromycin 500 mg

First Posted Date: 2019-11-20

Last Posted Date: 2020-08-17

Lead Sponsor: Brigham and Women's Hospital

Registration Number: NCT04171388

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Phase 4

Completed

Conditions: Venous Thromboembolism
Deep Vein Thrombosis
Pulmonary Embolism

Interventions: Drug: Apixaban 2.5 MG
Drug: Placebo oral tablet

First Posted Date: 2019-11-19

Last Posted Date: 2025-04-17

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 600

Registration Number: NCT04168203

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Even-Up to Minimize Secondary Site Pain For Ankle Fracture

Not Applicable

Terminated

Conditions: Arthralgia
Trouble Balancing

Interventions: Device: Even-Up

First Posted Date: 2019-11-15

Last Posted Date: 2022-10-18

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 6

Registration Number: NCT04164563

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy